Q/C Technologies, Inc. Earnings Per Share (Diluted)
Q/C Technologies, Inc. (QCLS) reported Earnings Per Share (Diluted) of -$0.79 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-12
- Q/C Technologies, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.79.
- Q/C Technologies, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.19.
- Q/C Technologies, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was -$1.13.
- Q/C Technologies, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$2.50.
- Q/C Technologies, Inc. earnings per share, diluted for fiscal 2025 was -$8.66.
- Q/C Technologies, Inc. earnings per share, diluted for fiscal 2024 was -$1080.87.
- Q/C Technologies, Inc. earnings per share, diluted for fiscal 2023 was -$5.33.
- Q/C Technologies, Inc. earnings per share, diluted for fiscal 2022 was -$11.74.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.79 10-Q · filed 2026-08-12 | -$0.99 10-Q · filed 2026-08-12 | -$1.92 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$2.88 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2026-03-31 | -$0.19 10-Q · filed 2026-05-15 | -$1.08 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$2.02 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$3.17 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2025-12-31 | -$1.13 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$2.60 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$4.67 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$8.66 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | -$2.50 10-Q · filed 2025-11-19 | -$5.99 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$14.77 10-Q · filed 2025-11-19 | -$4.51 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2025-06-30 | -$51.10 10-Q · filed 2026-08-12 | -$0.18 10-Q · filed 2025-08-19 | -$187.46 10-Q · filed 2026-08-12 | -$0.45 10-Q · filed 2025-08-19 | -$2.75 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$5.07 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||
| 2025-03-31 | -$0.36 10-Q · filed 2026-05-15 | -$1.19 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$2.84 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$7.65 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2024-12-31 | -$69.93 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$146.76 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$17.46 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$1080.87 10-K · filed 2026-04-15 | -$11.15 10-K · filed 2025-04-11 | |||
| 2024-09-30 | -$107.62 10-Q · filed 2025-11-19 | -$1.11 10-Q · filed 2024-11-14 | -$9.99 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$1015.18 10-Q · filed 2025-11-19 | -$10.49 10-Q · filed 2024-11-14 | -$15.16 derived: net income ÷ weighted average shares · filed 2025-11-19 | ||
| 2024-06-30 | -$4.54 10-Q · filed 2025-08-19 | -$9.58 10-Q · filed 2025-08-19 | -$10.48 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$5.04 derived: net income ÷ weighted average shares · filed 2025-11-19 | ||||
| 2024-03-31 | -$5.14 10-Q · filed 2025-05-15 | -$6.17 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$2.07 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$3.73 derived: net income ÷ weighted average shares · filed 2025-11-19 | ||||
| 2023-12-31 | -$1.31 derived: net income ÷ weighted average shares · filed 2025-04-11 | $0.35 derived: net income ÷ weighted average shares · filed 2025-04-11 | -$0.68 derived: net income ÷ weighted average shares · filed 2025-04-11 | -$5.33 10-K · filed 2025-04-11 | ||||
| 2023-09-30 | $0.37 10-Q · filed 2024-11-14 | $0.06 10-Q · filed 2023-11-14 | -$0.03 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$2.28 10-Q · filed 2024-11-14 | -$0.08 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | -$3.22 10-Q · filed 2024-08-19 | -$0.11 10-Q · filed 2023-08-14 | -$4.43 10-Q · filed 2024-08-19 | -$0.16 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | -$1.20 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | $0.03 derived: net income ÷ weighted average shares · filed 2024-04-01 | $0.21 derived: net income ÷ weighted average shares · filed 2024-04-01 | $1.01 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$11.74 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | -$0.09 10-Q · filed 2023-11-14 | -$0.19 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$0.30 10-Q · filed 2023-11-14 | |||||
| 2022-06-30 | -$0.09 10-Q · filed 2023-08-14 | -$0.20 10-Q · filed 2023-08-14 | ||||||
| 2017-09-30 | -$0.13 10-Q/A · filed 2018-07-13 | -$0.40 10-Q/A · filed 2018-07-13 | -$0.39 10-Q · filed 2017-11-14 | |||||
| 2016-09-30 | $0.06 10-Q/A · filed 2018-07-13 | -$0.41 10-Q/A · filed 2018-07-13 | ||||||
| 2015-09-30 | -$0.45 10-Q · filed 2016-11-14 | -$1.12 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |